Literature DB >> 6548661

Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study.

M Inamasu, N Oishi, T Chen, S Legha, J McCracken, S Balcerzak, R Stephens, R O'Bryan, S E Rivkin, J J Costanzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6548661

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  1 in total

1.  A novel acridine derivative, LS-1-10 inhibits autophagic degradation and triggers apoptosis in colon cancer cells.

Authors:  Wan Fu; Xue Li; Xiaopeng Lu; Luyao Zhang; Ran Li; Nan Zhang; Shan Liu; Xin Yang; Yue Wang; Ying Zhao; Xiangbao Meng; Wei-Guo Zhu
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.